#obesity

#obesity

Intermuscular fat increases the risk of heart attacks and heart failure, regardless of BMI.

Obesity is a serious health issue affecting various organs and increasing disease risks, necessitating better diagnosis methods beyond just BMI.

New guidelines aim to redefine obesity diagnosis beyond BMI, utilizing objective health measures.

Two new categories, clinical and pre-clinical obesity, assist in better categorizing obesity-related health risks.

Emphasis on stigma-free treatment approaches for all individuals living with obesity.

A committee has proposed redefining obesity to include more metrics beyond BMI, aiming for a better assessment of body composition.

Medicare and Medicaid are expanding access to anti-obesity drugs, addressing a significant barrier in treating obesity for millions of Americans.

Millions of Americans with obesity may gain Medicare/Medicaid coverage for weight-loss drugs, marking a significant policy shift and potential cost-saving.

Biden administration proposes Medicare and Medicaid coverage for obesity medications, allowing millions more Americans to access treatment for obesity.

Oprah Winfrey's perspective on weight and hunger changed after using GLP-1 drugs, challenging misconceptions about thin people and willpower.

Ozempic and similar drugs revolutionize obesity treatment by mimicking satiety hormones, offering new hope to individuals struggling with weight management.

Cook's experience underscores the emerging treatment strategies for obesity, focusing on Appetite suppression and muscle preservation.

Planning ahead during the holidays can help maintain weight loss goals.

Obesity medications like Mounjaro can reduce alcohol cravings and consumption among users, with many reporting decreased enjoyment in alcohol.

An innovative gastric balloon can inflate and deflate to improve weight loss effectiveness by simulating food intake.

GLP-1 drugs are potentially reversing America's obesity crisis with projected usage rising to 18 million by 2029.

GLP-1 weight-loss drugs may pose risks to vision, highlighting an ironic medical paradox.

Emerging obesity treatments like orforglipron and retatrutide show significant potential, possibly transforming the landscape of weight loss drugs in 2025.

Verdiva has raised $410 million to develop oral drugs for obesity, challenging established players by addressing unmet medical needs in weight loss.

The Biden administration proposes covering weight-loss injectables under Medicare and Medicaid, potentially aiding millions of obese Americans.

The Biden administration aims to provide free weight loss drugs to low-income individuals and retirees to combat obesity.

New Medicare and Medicaid rule could cover popular weight-loss drugs for millions of obese Americans, representing a significant shift in healthcare policy.

Powerful weight-loss drugs are increasing patient engagement and diagnoses of obesity-related conditions in the U.S. healthcare system.

BMI is an inadequate measure for diagnosing obesity and health risks.

Experts advocate for a more comprehensive assessment of health beyond just weight.

BMI is an imperfect tool indicating obesity and should be replaced or supplemented with better metrics.

Obesity can be categorized into clinical and preclinical to improve diagnosis and treatment.

A new framework for obesity diagnosis offers a more objective and globally applicable method.

Kimchi may aid in weight management and gut health for overweight adults, suggesting its potential as a dietary solution for obesity.

Cannabis is being researched for its potential in weight management and combating obesity.

Bernie Sanders is advocating for warning labels on ultra-processed foods to promote healthier choices and combat rising obesity rates among children.

A new weight-loss jab, Mounjaro, will be rolled out on the NHS, but the implementation may take up to 12 years due to service capacity concerns.

Robert F. Kennedy Jr. argues that access to healthy food is key to solving obesity and diabetes, criticizing reliance on drug treatments like Ozempic.

Cardiorespiratory fitness is a stronger predictor of mortality risk than body mass index (BMI).

Obese individuals who are fit have similar mortality risks as normal weight individuals who are fit.

Obesity in the U.S. military surged during the COVID-19 pandemic, impacting readiness and increasing health-related costs significantly.